# Title

 Food and Drugs. PART 338â€”NIGHTTIME SLEEP-AID DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE


# ID

 CFR-2018-title21-vol5.Pt. 338


# Structured Analysis Summary

| Type        | Values                                       |
|:------------|:---------------------------------------------|
| Constraints | ['within', 'more than']                      |
| Duration    | ['12.0 year', '2.0 week']                    |
| Condition   | ['subject to', 'when', 'if', 'unless']       |
| Entities    | ['Food', 'Indications', 'Scope', 'Insomnia'] |


# Structured Analysis With Context

 


## Constraints

| Constraints   | Context                                                                                                |
|:--------------|:-------------------------------------------------------------------------------------------------------|
| within        | consists of any of the following when used within the dosage limits established for each ingredient in |
| more than     | (2) &#8220;If sleeplessness persists continuously for  more than  2 weeks, consult your doctor.        |


## Duration

| Duration   | Context                                                                                                                      |
|:-----------|:-----------------------------------------------------------------------------------------------------------------------------|
| 12.0 year  | (1) &#8220;Do not give to children under 12 years of age.&#8221;                                                             |
| 2.0 week   | (2) &#8220;If sleeplessness persists continuously for more than 2 weeks, consult your doctor.                                |
| 12.0 year  | Adults and children 12 years of age and over: Oral dosage is 50 milligrams at bedtime if needed, or as directed by a doctor. |
| 12.0 year  | Adults and children 12 years of age and over: Oral dosage is 76 milligrams at bedtime if needed, or as directed by a doctor. |


## Condition

| Condition   | Context                                                                                                            |
|:------------|:-------------------------------------------------------------------------------------------------------------------|
| if          | as safe and effective and is not misbranded if it meets each condition in this part and                            |
| unless      | Regulations are to chapter I of title 21 unless  otherwise noted.                                                  |
| when        | the product consists of any of the following when used within the dosage limits established for each               |
| if          | product contains the established name of the drug, if  any, and ident                                              |
| subject to  | used, as provided in &#167;&#8201;330.1(c)(2) of this chapter, subject to the provisions of section 502 of the act |
| if          | (&#8220;Helps you&#8221; or &#8220;Reduces time to&#8221;) &#8220;fall asleep if  you have d                       |
| unless      | medical illness.&#8221; (3) &#8220;Do not take this product, unless directed by a doctor, if you have a            |
| if          | take this product, unless directed by a doctor, if you have a breathing problem such as emphysema                  |
| if          | take this product, unless directed by a doctor, if you have a breathing problem such as emphysema                  |
| if          | Do not take this product  if you are taking sedatives or tranquilizers, without first                              |
| if          | over: Oral dosage is 50 milligrams at bedtime if  needed, or as directed by a doctor.                              |
| if          | over: Oral dosage is 76 milligrams at bedtime if  needed, or as directed by a doctor.                              |


## Entities

| Entities    | Context                                                                                                 |
|:------------|:--------------------------------------------------------------------------------------------------------|
| Food        | Food  and Drugs.                                                                                        |
| Scope       | Scope .                                                                                                 |
| Indications | of the product states, under the heading &#8220; Indications ,&#8221; one or more of the phrases listed |
| Insomnia    | Insomnia may be a symptom of serious underlying medical                                                 |


